These data strongly suggest that PPM1A plays an important role in the regulation of the diabetic gene reprogramming by dephosphorylating PPARγ at Ser273, and that PPM1A may represent a therapeutic target for obesity and type 2 diabetes. Here, PPM1A is linked to obesity due to melanocortin 4 receptor deficiency.